Hard to see if and how GILD will be able to show TAF and its new combo pill are different from Viread's combo - Stribild and will the (possible) difference in efficacy and or safety would be enough when Viread goes generic.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.